Fortnightly review: Medical management of menorrhagia
- 20 November 1999
- Vol. 319 (7221) , 1343-1345
- https://doi.org/10.1136/bmj.319.7221.1343
Abstract
Excessive menstrual loss, or menorrhagia, is a significant healthcare problem in the developed world (box 1). In the United Kingdom, 5% of women of reproductive age will seek help for this symptom annually1; by the end of reproductive life the risk of hysterectomy (primarily for menstrual disorders) is 20%.2 This is also the situation in New Zealand.3 Objectively, menorrhagia is defined as a menstrual loss of 80 ml per month. Population studies have shown that this amount of loss is present in 10% of the population4 yet nearly a third of all women consider their menstruation to be excessive.5 This symptom thus creates a significant workload for health services. ### Box 1: Indications for referral to a gynaecologist or for surgical management RETURN TO TEXT In clinical medicine the paradigm of evidence based medicine currently holds sway. Evidence based medicine implies not only the application of effective treatments but their rational use within a rational overall management framework. In the management of excessive menstrual loss there is good evidence that many doctors do not necessarily prescribe the most effective treatments. In the United Kingdom, for example, more than a third of general practitioners prescribe norethisterone—arguably the least effective option—as first line treatment, whereas only 1 in 20 prescribe tranexamic acid—probably the most effective first line treatment.6 The problem is not confined to primary care. In New Zealand, where the use of tranexamic acid is restricted to secondary care, 50% of gynaecologists still use luteal phase progestogens, and less than 10% use tranexamic acid.7 #### Summary points Menorrhagia is an important healthcare issue Despite widely available evidence inappropriate treatments are being prescribed Guidelines exist for the appropriate management of menorrhagia Appropriate treatments enhance patient choice and may increase patient satisfaction Medical treatments may provide an …Keywords
This publication has 19 references indexed in Scilit:
- The levonorgestrel intrauterine system in the management of menorrhagiaBJOG: An International Journal of Obstetrics and Gynaecology, 1997
- How Do New Zealand Gynaecologists Treat Menorrhagia?Australian and New Zealand Journal of Obstetrics and Gynaecology, 1996
- Treatment of menorrhagia during menstruation: randomised controlled trial of ethamsylate, mefenamic acid, and tranexamic acidBMJ, 1996
- A simple visual assessment technique to discriminate between menorrhagia and normal menstrual blood lossObstetrics & Gynecology, 1995
- Pituitary and ovarian hormone levels in unexplained menorrhagia.1994
- Menstrual disturbances in thyrotoxicosis *Clinical Endocrinology, 1994
- Do British women undergo too many or too few hysterectomies?Social Science & Medicine, 1988
- An Objective Evaluation of Flurbiprofen and Tranexamic Acid in the Treatment of Idiopathic MenorrhagiaActa Obstetricia et Gynecologica Scandinavica, 1988
- The fibrinolytic enzyme system in normal menstruation and excessive uterine bleeding and the effect of tranexamic acidEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 1987
- Endometrial Morphology During Long-Term Use of Levonorgestrel-Releasing Intrauterine DevicesInternational Journal of Gynecological Pathology, 1986